Latest profit margin for Catalent: -9.34% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2024
Trailing 12 months ending Sep 2024
Catalent's profit margin stands at -9.34% as of September 2024. That compares with -22.36% in the prior-year period — up 58.2% year over year. That is below the Healthcare sector average of 9.48%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Catalent reported -9.34% in profit margin versus -22.36% a year earlier — a 58.2% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.
Catalent sits lower the Healthcare benchmark (9.48%) with a profit margin of -9.34%. That is roughly 198.5% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A profit margin of -9.34% for Catalent means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how Catalent's profit margin evolved across reporting periods, while the comparison chart places CTLT next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.